SXT1596 T19771
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
SXT1596 is a novel SS18-SSX/TLE1 interaction inhibitor. SXT1596 reduces cell viability and reactivates EGR1 expression in synovial sarcoma.
CAS nr:
5438-41-5
Purity:
98%
Molecular Weight:
207,19
SMILES:
C/C([N+]([O-])=O)=C\C1=CC=C(OCO2)C2=C1
Formula:
C10H9NO4
Pathway:
Target:
